Description
The BinaxNOW COVID-19 Ag Card rapid antigen test, which has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA), offers results in 15 minutes and is available as an aid to diagnose the virus that causes COVID-19. The BinaxNOW test can be displayed on Abbott’s new optional app - available at no charge - for iPhone and Android devices called NAVICA. This first-of-its-kind app will allow people who test negative to have a temporary encrypted digital health pass that displays their results.
Request Information
Features
Simple test procedure using a direct nasal swab
Direct nasal swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.
Onboard extraction allows the swab to be directly inserted into the test card
Cost-effective, high performing test designed for decentralized testing
Room temperature storage
Visually read results in 15 minutes - no instrument required Emergency Use Authorization (EUA) supports testing in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation†
Request Information
Specifications
Method: Lateral Flow
Time to Result: 15 minutes
Sample Type: Direct nasal swab
**Sensitivity (PPA): 97.1%
**Specificity (NPA): 98.5%
Kit Size: 40 Tests
Kit Contents:
40 Test Cards
40 Nasal Swabs
Positive Control Swab
Reagent Bottle
Package Insert
Procedure Card
40 Patient COVID-19 Fact Sheets
Healthcare Provider COVID-19 Fact Sheet
Request Information
